30.12.2006   

EN

Official Journal of the European Union

C 326/38


Reference for a preliminary ruling from the Verwaltungsgericht Köln (Germany) lodged on 2 November 2006 — Firma cp-Pharma Handels GmbH v Bundesrepublik Deutschland

(Case C-448/06)

(2006/C 326/80)

Language of the case: German

Referring court

Verwaltungsgericht Köln

Parties to the main proceedings

Applicant: Firma cp-Pharma Handels GmbH

Defendant: Bundesrepublik Deutschland

Question referred

Is Commission Regulation (EC) No 1873/2003 of 24 October 2003 (1) amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (2) void on account of a breach of higher-ranking Community law (Articles 1(1) and 3 of Council Regulation (EEC) No 2377/90 in conjunction with Article 4(1) of Council Directive 96/22/EC of 29 April 1996 (3)), in so far as application of an injection solution as a pharmaceutical form is excluded by virtue of the note marked (*) against the listing of progesterone in Annex II to Council Regulation (EEC) No 2377/90?


(1)  OJ 2003 L 275, p. 9.

(2)  OJ 1990 L 224, p. 1.

(3)  OJ 1996 L 125, p. 3.